lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer).
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...
i know major media won�t investigate medically-caused death numbers, because i�ve published reports for years, and i�ve contacted news people with the facts; and nothing happens..